{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Liraglutide+or+Placebo&page=2", "query": { "intervention": "Liraglutide or Placebo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 34, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Liraglutide+or+Placebo&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Liraglutide+or+Placebo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T02:23:39.909Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02518945", "title": "Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Insulin", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Dapagliflozin placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University at Buffalo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 26, "start_date": "2015-08", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2024-01-24", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02518945" }, { "nct_id": "NCT00781937", "title": "Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metabolism and Nutrition Disorder", "Obesity" ], "interventions": [ { "name": "liraglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 422, "start_date": "2008-10-30", "completion_date": "2010-09-01", "has_results": true, "last_update_posted_date": "2017-11-01", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 27, "location_summary": "Goodyear, Arizona • Peoria, Arizona • Huntington Beach, California + 22 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00781937" }, { "nct_id": "NCT02299388", "title": "To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Non-Insulin-Dependent", "Hypertensive Disease" ], "interventions": [ { "name": "Liraglutide or Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tulane University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 11, "start_date": "2014-10", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2021-01-27", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02299388" }, { "nct_id": "NCT01617434", "title": "The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "liraglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 451, "start_date": "2012-09", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2017-03-08", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Anaheim, California • Fresno, California + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Mateo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01617434" }, { "nct_id": "NCT03486392", "title": "A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "JNJ-64565111 Dose Level 1", "type": "DRUG" }, { "name": "JNJ-64565111 Dose Level 2", "type": "DRUG" }, { "name": "JNJ-64565111 Dose Level 3", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 474, "start_date": "2018-03-26", "completion_date": "2019-03-08", "has_results": true, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 17, "location_summary": "Phoenix, Arizona • Walnut Creek, California • Jacksonville, Florida + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Boise", "state": "Idaho" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03486392" }, { "nct_id": "NCT01618162", "title": "The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "insulin degludec/liraglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 435, "start_date": "2012-08-29", "completion_date": "2013-10-23", "has_results": true, "last_update_posted_date": "2017-10-27", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 44, "location_summary": "Anaheim, California • Garden Grove, California • La Jolla, California + 39 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01618162" }, { "nct_id": "NCT02443155", "title": "A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "NNC0114-0006", "type": "DRUG" }, { "name": "liraglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 308, "start_date": "2015-11-10", "completion_date": "2019-02-27", "has_results": true, "last_update_posted_date": "2021-04-09", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 13, "location_summary": "La Jolla, California • Northridge, California • Aurora, Colorado + 10 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02443155" }, { "nct_id": "NCT02911818", "title": "Lifestyle Modification and Liraglutide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "CMS-recommended lifestyle counseling", "type": "BEHAVIORAL" }, { "name": "Liraglutide 3.0mg", "type": "DRUG" }, { "name": "Portion-Controlled Diet", "type": "OTHER" }, { "name": "Placebo Oral Tablet", "type": "DRUG" }, { "name": "Phentermine 15 MG", "type": "DRUG" }, { "name": "Extension Study CMS-recommended lifestyle counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "DRUG", "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 150, "start_date": "2016-09", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2019-05-07", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02911818" }, { "nct_id": "NCT03712098", "title": "Daily Liraglutide for Nicotine Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Smoking Cessation", "Weight, Body" ], "interventions": [ { "name": "Liraglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Smoking Cessation Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Rebecca Ashare", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2018-11-29", "completion_date": "2022-05-25", "has_results": true, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03712098" }, { "nct_id": "NCT01272232", "title": "Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metabolism and Nutrition Disorder", "Obesity" ], "interventions": [ { "name": "liraglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 846, "start_date": "2011-06-01", "completion_date": "2013-01-25", "has_results": true, "last_update_posted_date": "2017-12-29", "last_synced_at": "2026-10-06T02:23:39.909Z", "location_count": 67, "location_summary": "Vestavia Hills, Alabama • Peoria, Arizona • Jonesboro, Arkansas + 57 more", "locations": [ { "city": "Vestavia Hills", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Concord", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01272232" } ] }